Literature DB >> 30963273

MRI predictive score of pial vascularization of supratentorial intracranial meningioma.

Guillaume Friconnet1, Victor Hugo Espíndola Ala2, Kevin Janot3, Waleed Brinjikji4, Clément Bogey2, Leslie Lemnos5, Henri Salle5, Suzana Saleme2, Charbel Mounayer2,6, Aymeric Rouchaud2,6.   

Abstract

OBJECTIVE: Meningiomas are highly vascularized tumors which may recruit pial blood supply. Pial supply complicates tumor treatment in numerous ways. The objective of this study was to establish a reliable MRI-based diagnostic score to predict the existence of pial blood supply in supratentorial intracranial meningiomas and then correlate the score with clinical and surgical outcomes and histopathological findings.
METHODS: We performed a retrospective analysis of supratentorial histologically proven meningiomas in our institution from 2010 to 2018. A score was built based on MRI criteria and correlated with digital subtraction angiography (DSA) pial vascularization assessment. The score was then validated on a second independent population recruited with the same modalities.
RESULTS: Logistic regression identified four parameters related to pial blood supply which were used to build the score: skull base location, tumor size > 45 mm, peritumoral flow voids, and incomplete cerebrospinal fluid rim. The overall diagnostic performance in predicting pial blood supply was as follows: sensitivity 97.8%, specificity 76.9%, predictive positive value 88.2%, negative predictive value 95.2%, and accuracy 90.3%. Inter-reader agreement and Cohen's kappa were good, respectively, of 90.7% and 0.69. A high score was associated with aggressive meningioma (World Health Organization II-III) (p = 0.04) and with greater importance of pial supply relative to dural supply.
CONCLUSIONS: We have identified a reliable way to use MRI to predict the existence of pial blood supply in supratentorial intracranial meningiomas. A higher score also predicted higher grade meningioma. KEY POINTS: • Accurate and reproducible MRI score composed of four items to predict the existence of pial blood supply in supratentorial meningioma. • High score is associated with high-grade meningioma (WHO II-III) but also with greater importance of pial supply relative to dural supply.

Entities:  

Keywords:  Magnetic resonance imaging; Meningioma; Retrospective studies; Supratentorial neoplasms

Mesh:

Year:  2019        PMID: 30963273     DOI: 10.1007/s00330-019-06197-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  16 in total

Review 1.  Preoperative endovascular embolization of meningiomas: update on therapeutic options.

Authors:  Aatman Shah; Omar Choudhri; Henry Jung; Gordon Li
Journal:  Neurosurg Focus       Date:  2015-03       Impact factor: 4.047

2.  Benign versus atypical meningiomas: risk factors predicting recurrence.

Authors:  Arkadiusz Nowak; Tomasz Dziedzic; Piotr Krych; Tomasz Czernicki; Przemysław Kunert; Andrzej Marchel
Journal:  Neurol Neurochir Pol       Date:  2014-11-28       Impact factor: 1.621

Review 3.  [Understanding logistic regression].

Authors:  M El Sanharawi; F Naudet
Journal:  J Fr Ophtalmol       Date:  2013-08-14       Impact factor: 0.818

4.  Preoperative embolization of intracranial meningiomas using n-butyl cyanoacrylate.

Authors:  Masanori Aihara; Isao Naito; Tatsuya Shimizu; Hiroya Fujimaki; Ken Asakura; Naoko Miyamoto; Yuhei Yoshimoto
Journal:  Neuroradiology       Date:  2015-04-07       Impact factor: 2.804

5.  The importance of pial blood supply to the development of peritumoral brain edema in meningiomas.

Authors:  M Bitzer; L Wöckel; A R Luft; A K Wakhloo; D Petersen; H Opitz; T Sievert; U Ernemann; K Voigt
Journal:  J Neurosurg       Date:  1997-09       Impact factor: 5.115

6.  Prediction of tumor-brain adhesion in intracranial meningiomas by MR imaging and DSA.

Authors:  Takashi Takeguchi; Hitoshi Miki; Teruhiko Shimizu; Keiichi Kikuchi; Teruhito Mochizuki; Shiro Ohue; Takanori Ohnishi
Journal:  Magn Reson Med Sci       Date:  2003-12-31       Impact factor: 2.471

7.  Most intracranial meningiomas are not cleavable tumors: anatomic-surgical evidence and angiographic predictibility.

Authors:  M P Sindou; M Alaywan
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

Review 8.  Contemporary endovascular embolotherapy for meningioma.

Authors:  Gregory J Dubel; Sun Ho Ahn; Gregory M Soares
Journal:  Semin Intervent Radiol       Date:  2013-09       Impact factor: 1.513

9.  The rim pattern of meningioma on 3D FLAIR imaging: correlation with tumor-brain adhesion and histological grading.

Authors:  Mikako Enokizono; Minoru Morikawa; Takayuki Matsuo; Tomayoshi Hayashi; Nobutaka Horie; Sumihisa Honda; Reiko Ideguchi; Izumi Nagata; Masataka Uetani
Journal:  Magn Reson Med Sci       Date:  2014-08-27       Impact factor: 2.471

10.  The Meningioma Vascularity Index: a volumetric analysis of flow voids to predict intraoperative blood loss in nonembolized meningiomas.

Authors:  Carlito Lagman; Vera Ong; Thien Nguyen; Yasmine Alkhalid; John P Sheppard; Prasanth Romiyo; Daniel Azzam; Giyarpuram N Prashant; Reza Jahan; Isaac Yang
Journal:  J Neurosurg       Date:  2018-06-01       Impact factor: 5.115

View more
  3 in total

1.  MRI multiparametric scoring system for pial blood supply of intracranial meningiomas.

Authors:  Fumiyo Higaki; Satoshi Inoue; Wakako Oda; Eiji Matsusue; Takao Hiraki
Journal:  Acta Radiol Open       Date:  2022-04-08

Review 2.  Updated Systematic Review on the Role of Brain Invasion in Intracranial Meningiomas: What, When, Why?

Authors:  Lara Brunasso; Lapo Bonosi; Roberta Costanzo; Felice Buscemi; Giuseppe Roberto Giammalva; Gianluca Ferini; Vito Valenti; Anna Viola; Giuseppe Emmanuele Umana; Rosa Maria Gerardi; Carmelo Lucio Sturiale; Alessio Albanese; Domenico Gerardo Iacopino; Rosario Maugeri
Journal:  Cancers (Basel)       Date:  2022-08-27       Impact factor: 6.575

3.  Magnetic Resonance Imaging (MRI) Differential Diagnosis of Meningiomas Using ANOVA.

Authors:  Jinhuan Liu; Jun Chen; Yunfei Zha; Yabin Huang; Feifei Zeng
Journal:  Contrast Media Mol Imaging       Date:  2021-07-10       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.